Cetuximab, Capecitabine and Oxaliplatin in Patients With Epidermal Growth Factor Receptor (EGFr) Expressing Metastatic Colorectal Cancer

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
ImClone LLC
Bristol-Myers Squibb
Information provided by:
New York University School of Medicine
ClinicalTrials.gov Identifier:
NCT00444678
First received: March 7, 2007
Last updated: March 6, 2013
Last verified: March 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: August 2013
  Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)